Cargando…

Jinhua Qinggan Granule UHPLC-Q-extractive-Orbitrap-MS assay: Putative identification of 45 potential anti-Covid-19 constituents, confidential addition, and pharmacopoeia quality-markers recommendation

The study combined UHPLC-Q-Orbitrap-MS analysis with authentic standards, to create a novel strategy for isomers recognition and putative identification. Through the strategy, anti-Covid-19 Jinhua Qinggan Granule was found to comprise 28 isomers and 45 potential anti-Covid-19 constituents. The detec...

Descripción completa

Detalles Bibliográficos
Autores principales: Zeng, Jingyuan, Li, Xican, Cai, Rongxin, Li, Chunhou, Chen, Shaoman
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taiwan Food and Drug Administration 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10629912/
http://dx.doi.org/10.38212/2224-6614.3466
_version_ 1785132047477506048
author Zeng, Jingyuan
Li, Xican
Cai, Rongxin
Li, Chunhou
Chen, Shaoman
author_facet Zeng, Jingyuan
Li, Xican
Cai, Rongxin
Li, Chunhou
Chen, Shaoman
author_sort Zeng, Jingyuan
collection PubMed
description The study combined UHPLC-Q-Orbitrap-MS analysis with authentic standards, to create a novel strategy for isomers recognition and putative identification. Through the strategy, anti-Covid-19 Jinhua Qinggan Granule was found to comprise 28 isomers and 45 potential anti-Covid-19 constituents. The detection of three constituents (Danshensu, cryptotanshin, and tanshinone IIA) suggests Danshen as confidential additive. Based on this, 6 constituents are recommended as quality-marker candidates, including chlorogenic acid, acteoside, peimisine, baicalein, licoricesaponin H2, and tanshinone IIA. Obviously, the study can not only help the public to really understand the Granule’s formula and chemistry, but also facilitate its Pharmacopoeia collection in future.
format Online
Article
Text
id pubmed-10629912
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Taiwan Food and Drug Administration
record_format MEDLINE/PubMed
spelling pubmed-106299122023-11-08 Jinhua Qinggan Granule UHPLC-Q-extractive-Orbitrap-MS assay: Putative identification of 45 potential anti-Covid-19 constituents, confidential addition, and pharmacopoeia quality-markers recommendation Zeng, Jingyuan Li, Xican Cai, Rongxin Li, Chunhou Chen, Shaoman J Food Drug Anal Original Article The study combined UHPLC-Q-Orbitrap-MS analysis with authentic standards, to create a novel strategy for isomers recognition and putative identification. Through the strategy, anti-Covid-19 Jinhua Qinggan Granule was found to comprise 28 isomers and 45 potential anti-Covid-19 constituents. The detection of three constituents (Danshensu, cryptotanshin, and tanshinone IIA) suggests Danshen as confidential additive. Based on this, 6 constituents are recommended as quality-marker candidates, including chlorogenic acid, acteoside, peimisine, baicalein, licoricesaponin H2, and tanshinone IIA. Obviously, the study can not only help the public to really understand the Granule’s formula and chemistry, but also facilitate its Pharmacopoeia collection in future. Taiwan Food and Drug Administration 2023-08-31 /pmc/articles/PMC10629912/ http://dx.doi.org/10.38212/2224-6614.3466 Text en © 2023 Taiwan Food and Drug Administration https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC-BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) ).
spellingShingle Original Article
Zeng, Jingyuan
Li, Xican
Cai, Rongxin
Li, Chunhou
Chen, Shaoman
Jinhua Qinggan Granule UHPLC-Q-extractive-Orbitrap-MS assay: Putative identification of 45 potential anti-Covid-19 constituents, confidential addition, and pharmacopoeia quality-markers recommendation
title Jinhua Qinggan Granule UHPLC-Q-extractive-Orbitrap-MS assay: Putative identification of 45 potential anti-Covid-19 constituents, confidential addition, and pharmacopoeia quality-markers recommendation
title_full Jinhua Qinggan Granule UHPLC-Q-extractive-Orbitrap-MS assay: Putative identification of 45 potential anti-Covid-19 constituents, confidential addition, and pharmacopoeia quality-markers recommendation
title_fullStr Jinhua Qinggan Granule UHPLC-Q-extractive-Orbitrap-MS assay: Putative identification of 45 potential anti-Covid-19 constituents, confidential addition, and pharmacopoeia quality-markers recommendation
title_full_unstemmed Jinhua Qinggan Granule UHPLC-Q-extractive-Orbitrap-MS assay: Putative identification of 45 potential anti-Covid-19 constituents, confidential addition, and pharmacopoeia quality-markers recommendation
title_short Jinhua Qinggan Granule UHPLC-Q-extractive-Orbitrap-MS assay: Putative identification of 45 potential anti-Covid-19 constituents, confidential addition, and pharmacopoeia quality-markers recommendation
title_sort jinhua qinggan granule uhplc-q-extractive-orbitrap-ms assay: putative identification of 45 potential anti-covid-19 constituents, confidential addition, and pharmacopoeia quality-markers recommendation
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10629912/
http://dx.doi.org/10.38212/2224-6614.3466
work_keys_str_mv AT zengjingyuan jinhuaqinggangranuleuhplcqextractiveorbitrapmsassayputativeidentificationof45potentialanticovid19constituentsconfidentialadditionandpharmacopoeiaqualitymarkersrecommendation
AT lixican jinhuaqinggangranuleuhplcqextractiveorbitrapmsassayputativeidentificationof45potentialanticovid19constituentsconfidentialadditionandpharmacopoeiaqualitymarkersrecommendation
AT cairongxin jinhuaqinggangranuleuhplcqextractiveorbitrapmsassayputativeidentificationof45potentialanticovid19constituentsconfidentialadditionandpharmacopoeiaqualitymarkersrecommendation
AT lichunhou jinhuaqinggangranuleuhplcqextractiveorbitrapmsassayputativeidentificationof45potentialanticovid19constituentsconfidentialadditionandpharmacopoeiaqualitymarkersrecommendation
AT chenshaoman jinhuaqinggangranuleuhplcqextractiveorbitrapmsassayputativeidentificationof45potentialanticovid19constituentsconfidentialadditionandpharmacopoeiaqualitymarkersrecommendation